HHS nominee Azar says drug pricing a top priority

WASHINGTON (Reuters) - Alex Azar, the Republican nominee to head the U.S. Department of Health and Human Services and a former Eli Lilly & Co top executive, said on Wednesday that drug prices are too high and pledged to work on solutions despite his industry background.